Introduction
The v-ski gene was originally identi®ed as the transforming gene of the avian Sloan-Kettering retroviruses, which transform chicken embryonic ®broblasts (Li et al., 1986) . The cellular homologue c-ski has been identi®ed from several species, including human, chicken, and Xenopus (Nomura et al., 1989; Stavnezer et al., 1989; Sutrave and Hughes, 1989; Sleeman and Laskey, 1993) . The chicken c-ski proto-oncogene products (c-Ski) are nuclear proteins of 750 amino acids Sutrave and Hughes, 1989; Sutrave et al., 1990a) . The ski gene family contains another member, sno (ski-related novel) gene (Nomura et al., 1989) . The sno gene also has transforming capacity, and overexpression of sno leads to transformation of chicken embryo ®broblasts (Boyer et al., 1993) . Ski is a unique oncogene in that, in addition to aecting cell growth, it is also involved in regulation of muscle dierentiation. Overexpression of Ski induces muscle dierentiation in embryo ®broblasts (Colmenares and Stavnezer, 1989; Colmenares et al., 1991) and causes postnatal hypertrophy of type II fast muscle ®bers in transgenic mice (Sutrave et al., 1990b) . Furthermore, mice lacking c-ski display decreased myo®ber development in addition to abnormalities in pattern formation such as defects in neuronal and craniofacial patterning (Berk et al., 1997) . Thus, c-Ski has the multiple roles in the regulation of cellular proliferation and development.
c-Ski is localized to the nucleus (Sutrave et al., 1990a ) and binds to DNA in association with other cellular factors (Nagase et al., 1990) . Ski can function as a transcriptional repressor via the speci®c DNA sequence (Nicol and Stavnezer, 1998) . Recently we demonstrated that c-Ski and Sno act as co-repressors . c-Ski directly binds to the two co-repressors NCoR/SMRT (HoÈ rlein et al., 1995; Chen and Evans, 1995) and mSin3A (Ayer et al., 1995) . mSin3A and NCoR/SMRT also interact each other, and form a macromolecular complexes with histone deacetylase (HDAC), respectively (Heinzel et al., 1997; Alland et al., 1997; Hassing et al., 1997; Laherty et al., 1997; Nagy et al., 1997) . Ski and Sno are required for transcriptional repression by multiple repressors in-cluding Mad and thyroid hormone receptor b , and modulate the transcriptional regulation mediated by retinoid receptor a (Dahl et al., 1998) . The multiple roles of c-Ski described above in the regulation of cellular proliferation and development may re¯ect the capacity of Ski to associate with a wide range of dierent transcriptional regulators. In contrast to the role of c-Ski in the transcriptional repression elicited by multiple repressors, c-Ski also binds to transcriptional activator and inhibits its activity. c-Ski was recently demonstrated to directly bind to Smad proteins and recruits the HDAC complex to Smad proteins, leading to the inhibition of Smad proteinsdependent transcriptional activation (Sun et al., 1999; Luo et al., 1999; Akiyoshi et al., 1999; Xu et al., 2000) . Smad proteins induce the transcription of a group of target genes upon TGF-b stimulation (for a review, see MassagueÂ and Wotton, 2000) , indicating that c-Ski negatively regulates TGF-b signaling. Since TGF-b inhibits cellular proliferation at least partly by inducing the expression of the Cdk4/6 inhibitor p15 INK4B (Hannon and Beach, 1994) , this ®nding is consistent with the view that ski possesses the transforming capacity of an oncogene.
In contrast to its function as an oncogene, c-Ski is required to mediate transcriptional repression by two tumor suppressors, Mad and Rb Tokitou et al., 1999) . Mad proteins, containing the bHLH domain, acts as transcriptional repressors after heterodimerization with Max . The same target sequence of Mad/Max is also recognized by a heterodimer of Myc/Max, which activates transcription. Myc/Max enhances cellular proliferation or transformation, whereas Mad/Max leads to suppression of proliferation or induction of terminal dierentiation Roussel et al., 1996; Chin et al., 1995) . The role of Mad as a tumor suppressor was demonstrated by the observation that mutant mice lacking mxi1, a member of the mad gene family, showed increased susceptibility to tumorigenesis (Schreiber-Agus et al., 1998) . The product of the Rb tumor suppressor gene negatively regulates the G1/S transition in the cell cycle by silencing a group of target genes regulated by E2F transcription factors (for a review, see Weinberg, 1995; Nevins, 1992) . Rb recruits the HDAC complex to E2F, and actively represses the transcription of S phase-speci®c genes (Brehm et al., 1998; MagnaghiJaulin et al., 1998; Luo et al., 1998) . Thus, Mad and Rb play an important role in the negative regulation of the G1/S transition. Up to now, multiple target genes, which are down-regulated by Mad or Rb, have been identi®ed (for a review, see Grandori and Eisenman, 1997; Muller and Helin, 2000) . The most famous among these is cdc25A (Galaktionov et al., 1996; Neufeld et al., 1998) . Activation of cyclindependent kinases (Cdks) can be achieved through their dephosphorylation by members of the Cdc25 phosphatase family. By regulating Cdk activities, Cdc25A plays an important role at the G1/S phase transition. Requirement of c-Ski for transcriptional repression by Mad and Rb Tokitou et al., 1999) suggest that ski may function as a tumor suppressor at least in some types of cells.
To investigate the possibility that ski acts as a tumor suppressor, we analysed the ski heterozygous mutant mice. Here we demonstrate that loss of one copy of ski increases susceptibility to tumorigenesis in mice.
Results
Tumor susceptibility of ski +/7 mice
To examine the possibility that ski might act as a tumor suppressor, we compared the tumor susceptibility of ski +/7 mice and wild-type littermates during a course of intraperitoneal injections of the carcinogen 9,10-dimethyl-1,2-benzanthracene (DMBA). Over an observation period of 90 days, 96% of the wildtype male mice (n=23), 91% of the wild-type female mice (n=22), 52% of the ski +/7 male mice (n=21), and 30% of the ski +/7 female mice (n=20) survived this treatment and remained free of clinicallyapparent tumors (P50.001) (Figure 1a ). In total, 23 ski +/7 mice died with grossly-visible tumors, most of which were malignant lymphomas as judged by Giemsa staining and immunostaining. Twenty mice developed lymphomas. Of these, ®fteen were T-cell, one was B cell, and four were of indeterminate origin (negative for the T-cell and B-cell markers of CD3, Thy 1.2, B220, and IgM). Two mice developed myelocytic leukemia and one mouse developed megakaryocytic leukemia. Histological analysis of lymphomas in ski +/7 mice homogeneously expressing the T-cell marker Thy-1.2 (T lymphomas) is shown in Figure 1b .
Most of the tumor suppressors examined to date ful®l Knudson's`two-mutation' criterion (Knudson, 1971 (Knudson, , 1997 , which dictates that loss of the wild-type allele or impaired expression of the tumor suppressor protein causes tumorigenesis in cells that normally express the tumor suppressor gene. Studies of various tumor suppressor genes have indicated that loss of expression from the wild-type allele is caused by multiple mechanisms including rearrangement or deletion of the gene, point mutation, and methylation. To determine whether expression of Ski protein from the wild-type allele in ski +/7 mice was lost in tumors, we carried out immunostaining of Ski protein in tumor cells. Among the nine DMBA-induced tumors examined, Ski protein could not be detected in three of them (33%; Figure 1C ). Thus, ski ful®ls Knudson's two-mutation' criterion for a tumor suppressor gene (Knudson, 1997) . Due to diculties of isolating enough amounts of tumor cells, we could not analyse whether the wild-type allele in the remaining six tumors, all of which showed Ski expression, has a mutation or not. Therefore, we cannot exclude the possibility that the mutated Ski protein is expressed in these tumors (see Discussion).
Growth properties of ski 7/7 MEFs
Since ski-de®cient mice were alive at E15.5 (Berk et al., 1997) , mouse embryonic ®broblasts (MEFs) were prepared from ski homozygous mutant embryos. We next assayed the proliferation properties of exponentially growing MEFs using growth curves and¯ow cytometry. Although the wild-type, ski
, and ski 7/7 cells were morphologically indistinguishable at low density, ski +/7 and ski 7/7 MEFs grew faster than wild-type MEFs derived from littermates ( Figure 2a ). In addition, ski +/7 and ski 7/7 MEF monolayers achieved 30% higher cell densities than wild-type MEFs (Figure 2a ). Analysis of cell-cycle pro®les indicated that the S phase populations of ski 7/7 and wild-type cells were 28.8% and 19.5%, respectively ( Figure 2b ), indicating an approximately 48% increase in the S phase population of ski 7/7 cells relative to the wild type. These results suggest that ski 7/7 MEFs have a defect in cell cycle arrest.
As a further measure of proliferative potential, we compared the abilities of ski 7/7 , ski +/7 , and wildtype MEFs to form colonies in methylcellulose after infection with murine leukemia virus (MuLV) carrying the v-K-ras oncogene. ski 7/7 MEFs and ski +/7 MEFs generated 74 ± 165 and 21 ± 47 colonies per 10 3 cells, respectively, whereas wild-type MEFs generated only a few colonies (Table 1) . Under the same conditions, p53-de®cient MEFs produced 230 colonies per 10 3 cells (data not shown). MEFs expressing the v-K-ras oncogene were injected subcutaneously into nude mice, and tumor formation was examined. Like p53-de®cient MEFs, ski
7/7
MEFs expressing v-K-ras were signi®cantly tumorigenic in nude mice, although the tumor-forming capacity of wild-type and ski
MEFs was undetectable (Table 1, 
Suppression of growth of MEFs by c-ski
Enhanced growth of the ski +/7 and ski 7/7 MEFs compared to the wild-type MEFs suggested the role for c-ski in the negative regulation of cell proliferation. In addition to the loss-of-function study, we also investigated whether over expression of c-ski suppresses the growth of MEFs. For this purpose, we constructed the retrovirus vector encoding the human wild-type cski (pMSCV-ski-ir-GFP), and generated the recombinant viral stock of enough titer. Infection of wild-type MEFs with this recombinant virus led to high-level expression of c-Ski (Figure 3a) . Although these cells were morphologically indistinguishable from the noninfected control MEFs, infection with the ski-expression virus almost completely blocked the growth of MEFs (Figure 3b ). Analysis of cell-cycle pro®les indicated that the S phase populations of the mockand ski virus-infected cells were 22.0% and 13.7%, respectively (Figure 3c ). Thus, there was about a 38% decrease in the S phase population of ski virus-infected cells relative to the mock-infected cells. These results suggest that overexpression of c-Ski leads to the arrest of the cell cycle at G1 phase.
Regulation of expression of the cdc25A gene by c-ski
We previously demonstrated that c-Ski and Sno are required for the transcriptional repression mediated by two tumor suppressors Mad and Rb Tokitou et al., 1999) . Both Mad and Rb play an important role in the negative regulation of cell cycle progression and down regulate the transcription of cdc25A (Galaktionov et al., 1996; Neufeld et al., 1998) . We speculated that the increased proliferation of ski 7/7 MEFs was at least partly due to the decreased activities of Mad and Rb. Therefore, we examined the cdc25A mRNA levels in wild-type and ski 7/7 MEFs (Figure 4a ). The levels of cdc25A mRNA in ski +/7 and ski 7/7 cells were 2.8-and 2.1-fold higher than that of the wild type, respectively. Consistent with this, the level of cdc25A mRNA in the MEFs infected with the c-ski expression virus was decreased to 34% of that of mock-infected cells (Figure 4b) . Theses results support the view that decreases in the activities of two tumor suppressors Mad and Rb in the ski-de®cient cells at least partly contributed to enhanced proliferation and susceptibility to tumorigenesis. Left column, the number of colonies generated in a methylcellulose gel after infection with murine leukemia virus carrying the activated K-ras oncogene. Experiments were repeated three times, and the average number of colonies formed per 10 3 cells is indicated together with the strand deviation. Right column, number of tumors formed after injecting nude mice with cells expressing v-K-ras. ND, not determined 
High resolution mapping of the human c-ski gene
To investigate whether the human ski gene is localized at the locus where other suspected tumor suppressor genes have been previously mapped, we determined the position of the human c-ski gene on human chromosomes by using the RH mapping method. The human c-ski gene was mapped to the 1p36.3 locus. Among the markers contained in the GENEBRIDGE 4 RH Panel, the ski gene was located furthest from the centromere and 30.1 centi-ray away from the NIB1364 marker (Figure 5a ). To precisely determine the position of the human c-ski gene, and especially its location with respect to that of the well-known tumor suppressor gene p73 also located in this region, we performed high resolution FISH mapping using three probes (D1S80 (Martinsson et al., 1995) , p73 (Kaghad et al., 1997) , and ski) (Figure 5b,c) . The data indicated that the D1S80 marker was located between the ski and p73 genes, and separated by 285 kb (SEM: 70 kb) and 610 kb (SEM: 150 kb) from the ski and p73 genes, respectively. Thus, the human ski gene is localized at the 1p36.3 locus, a region already known to contain uncharacterized tumor suppressor genes (Cheng et al., 1995; Ichimiya et al., 1999; Imyanitov et al., 1999; Mori et al., 1998) .
Discussion
Although ski is generally considered to be oncogene, the susceptibility of ski +/7 mice to carcinogen-induced tumors in this study indicates that ski acts as a tumor suppressor at least in some types of cells. Recently, we also observed that mice lacking one copy of the skirelated gene sno showed an increased level of tumor formation relative to wild-type mice when challenged with a chemical carcinogen (Shinagawa et al., 2000) . Thus, both Ski and Sno function as either oncoproteins or tumor suppressors. Since mounting evidence Two color FISH experiments demonstrate the relative distance between ski (green) and p73 (red) (left), between D1S80 (green) and p73 (red) (middle), and between ski (green) and D1S80 (red) (right). (c) Schematic representation of the positions of the ski gene, D1S80 marker, and p73 gene. The distances between these three genes were determined by using the data from two color FISH experiments ski acts as a tumor suppressor in mice T Shinagawa et al suggests that c-Ski and Sno can form a complex through their C-terminal coiled-coil region (Nagase et al., 1993; Heyman and Stavnezer, 1994) , c-Ski and Sno likely possess similar function. Spontaneous tumors have already been observed in sno-heterozygous mice with low frequency (Shinagawa et al., 2000) , but not in ski-heterozygous mice, suggesting that sno may be a stronger tumor suppressor than ski. Ski protein was not detected in three out of nine DMBA-induced tumors. There were no large solid tumors developed in ski +/7 mice, and all the tumor cells were entangled with the normal cells. Due to these reasons, we could not completely purify the enough amounts of tumor cells. Therefore, we could not further analyse whether the wild-type allele in the remaining six tumors, which showed Ski expression, has a mutation or not. As shown in Figures 2a and 4a , loss of either one or two alleles of c-ski led to higher cell density and increased expression of Cdc25A gene. These results suggest that tumors were developed in c-ski +/7 mice both by loss of two c-ski alleles (Knudson type tumor suppressor) and also by haploinsuciency.
Although they have been considered oncogenes to date, both c-ski and sno genes act as a tumor suppressor at least in some types of cells. Similar observations have been made concerning E2F-1 and PML. Enforced expression of E2F-1 in cultured cells induces transformation, but E2F-1-de®cient mice develop various types of tumors (Yamasaki et al., 1996; Field et al., 1996) . The PML gene was originally identi®ed as a PML-RAR fusion oncogene that caused acute promyelocytic leukemias (APL); however, later studies showed it to be a tumor suppressor gene (Doucas and Evans, 1996; Wang et al., 1998) . Since both c-Ski and Sno inhibit TGF-b-induced transcriptional activation (Sun et al., 1999; Luo et al., 1999; Akiyoshi et al., 1999; Xu et al., 2000) , Ski-mediated inhibition of TGF-b signaling likely contributes at least partly to Ski-induced transformation of TGF-bsensitive cells. On the other hand, c-Ski and Sno are needed for the transcriptional repression mediated by Mad and Rb Tokitou et al., 1999) . Since both Mad and Rb appear to induce cell cycle arrest (Zhang et al., 1999; Goodrich and Lee, 1992; Leone et al., 1997) , the defect in cell cycle arrest observed in ski 7/7 MEFs could be at least partly due to decreased Mad and/or Rb activity. In fact, the cdc25A gene, which is one of the most well-known target genes of Rb and Mad (Galaktionov et al., 1996; Neufeld et al., 1998) , is up regulated in ski 7/7 MEFs and down-regulated by over expression of c-Ski ( Figure  4 ). Similar cell cycle arrest and upregulation of cdc25A gene was also observed in sno +/7 MEFs (Shinagawa et al., 2000) . Expression of c-ski mRNA peaks in mid G1 phase of the cell cycle in hematopoietic cells, while expression of sno mRNA is maximal in early to mid G1, although its levels oscillate throughout the rest of the cell cycle (Pearson-White et al., 1995) . Together with our results, these observations suggest that c-Ski and Sno play an important role in the negative regulation of the G1/S transition.
The level of cdc25A mRNA in ski 7/7 cells was higher than that of the wild type (Figure 4) . However, upregulation of cdc25A gene may be one of the multiple mechanisms for tumor formation by loss of c-Ski. Recently, we found that c-Ski is required for methyl CpG-dependent gene silencing via directly interacting with methyl-CpG-binding protein, MeCP2 (Kokura et al., 2001) . If expression of some protooncogenes is repressed by methylation of their promoter regions, loss of c-Ski would enhance expression of those oncogenes, leading to transformation. Recently, it was reported that tumor suppressor p53 represses transcription through interacting with corepressor mSin3A (Murphy et al., 1999) . The p53-dependent transcriptional repression of some genes is thought to be important for the p53-induced apoptosis. Since c-Ski directly binds to mSin3A, it is not an unlikely possibility that both c-Ski and mSin3 are required for the p53-induced transcriptional repression. Thus, loss of c-Ski may increase the susceptibility to tumorigenesis via multiple mechanisms.
The human c-ski gene maps to 1p36.3 ( Figure 5 ), close to the reported location of multiple uncharacterized tumor suppressor genes for neuroblastoma (Cheng et al., 1995; Ichimiya et al., 1999) , ovarian adenocarcinomas (Imyanitov et al., 1999) , and chronic myelocytic leukemia (Mori et al., 1998) . The sno gene is located between 3q26.31 and 3q26.32 (Shinagawa et al., unpublished results) , where one of the highest frequencies of loss of constitutional heterozygosity in human osteosarcoma has also been mapped (Kruzelock et al., 1997) . Elderly people sustain a high rate of epithelial cancers by loss of tumor suppressor gene, whereas mice carrying common tumor suppressor gene mutations typically develop lymphomas and soft tissue sarcomas. Due to this species variance, the loss of c-ski or sno may increase the susceptibility of mice to lymphomas, but yield other type(s) of cancer in human. The results in this study raise the possibility that loss of human ski gene family function may increase the susceptibility of human to certain types of tumors.
Materials and methods

Histological analysis and immunohistochemistry
The generation of ski-de®cient mutant mice was described previously (Berk et al., 1997) . Mice were backcrossed onto the C57BL/6J background for at least four generations. Tissues were ®xed in 4% paraformaldehyde, dehydrated and embedded in paran. Sections (5 mm) were stained with haematoxylin and eosin according to standard procedures. Paran sections of 4 mm were used for immunohistochemistry.
Phycoerythrin-conjugated anti-Thy-1.2, anti-CD3-e, and anti-B220 antibodies (30-H12, 500A2, and RA3-6B2, respectively; Pharmingen) were used for immunostaining. For Ski protein staining, deparanized sections were incubated in 3% H 2 O 2 for 10 min to block endogenous peroxidase. Specimens were placed in microwave for 10 min in the presence of 10 mM sodium citrate (pH 6.0) and then treated with 0.3% Triton X-100 in PBS for 10 min at room temperature. Samples were then incubated overnight at 378C with a mixture of anti-Ski monoclonal antibodies 1 ± 1, 9 ± 1, 11 ± 1, and 16 ± 1 (1 : 50). Horseradish peroxidase-conjugated antimouse IgG1 antibody was used as the secondary antibody and DAB as the chromogen. Isotype-matched mouse antibody (IgG1) was used as a negative control.
DMBA tumorigenic treatment
A lipid emulsion of 9,10-dimethyl-1,2-benzanthracene (DMBA) (0.5% w/w, Sigma) was administered to 2 ± 3 month-old mice three times at 2-week intervals via intraperitoneal injection (17.5 mg/kg body weight). Mice were monitored regularly and killed when their overall health was compromised. A full histopathological survey was conducted on the ®rst 8 ± 10 mice in each cohort; thereafter, detailed pathological analysis was restricted to the site of tumor involvement and organs of potential metastatic involvement.
Analysis of embryonic fibroblasts
Mouse primary embryonic ®broblasts (MEFs) were isolated from embryos at 14.5 and 15.5 d.p.c. For growth curves, cells at passage 3 were grown from a starting density of 3610 4 cells per well in 24-well plates in DMEM supplemented with 10% fetal bovine serum. Nine independent experiments were carried out from three dierent MEF preparations. For cell cycle analysis, exponentially growing cells were suspended in 50 mg/ml propidium iodide (Sigma), 4 mM sodium citrate, 150 mM NaCl, 0.5 mg/ml RNase A, and 0.05% Nonidet P-40, and were analysed by FACScan (Becton Dickinson). Cell cycle distributions were analysed using the CellQuest and ModFit LT software packages. For colony-formation assays, MEFs were infected with murine leukemia virus (MuLV) carrying the activated K-ras oncogene (MOI=1). After 48 h, 3610 4 cells were suspended in 1.3% methylcellulose gel dissolved in culture medium and overlaid on an agarose bed composed of 0.53% agarose in culture medium. Colonies were scored 3 weeks after plating. To test the tumorigenicity of the cell clones, subcutaneous injection of nude mice (BALB/c nu/nu; Clea Japan Inc.) was performed with 10 6 cells in 200 ml of DMEM without FCS. Cells were scored as tumorigenic if a visible nodule more than 2 mm in diameter appeared at the site of injection at 10 days after injections.
Generation of retroviral expression plasmid for human c-ski
The human full-length c-ski cDNA was cloned into the 5' side of the ribosome entry site of the MSCV (murine stem cell virus)-based retroviral vector (Persons et al., 1997) to generate the plasmid pMSCV-ski-ir-GFP. The ecotropic virus packaging cells BOSC23 (Pear et al., 1993) were transfected with the pMSCV-ski-ir-GFP DNA, and conditioned media were prepared. The viral titer in conditioned media was approximately 2.6610 5 particles/ml as assessed by transfer of the GFP marker to wild-type MEFs. MEFs were infected with this virus (MOI=1) for 24 h, and after replacement of medium, growth curve and cell cycle analysis were made as described above.
Northern analysis
For the comparison of wild-type and ski-de®cient MEFs, cells were seeded at 3610 5 cells per 10 cm dish and exponentially growing cells were harvested 2 days later to prepare RNA. To examine the eect of over expression of c-Ski, wild-type MEFs were infected with the retrovirus expressing c-Ski as described above (MOI=1) for 24 h. Then, the medium was replaced and cells were cultivated for an additional 24 h before RNA preparation. Total RNA was isolated by Isogen (Nippon Gene, Japan) and 20 mg of total RNA was electrophoresed in a 1% agarose formaldehyde gel, and then transferred to a Hybond-N + membrane (Amersham). The blot was hybridized with cdc25A or GAPDH 32 P-labeled probes.
Chromosomal localization
Radiation hybrid (RH) panel (Genebridge 4 RH Panel, Research Genetics, Inc.) screening was generally done according to the manufacturer's protocol. The following two primers were used for PCR: hski-1, 5'-CGTGGTGGGAGGCGAGAAGC-3' (human c-ski mRNA position 411-430), and hski-2, 5'-CCAGCAGCCCCTTA-CACTTG-3' (human c-ski mRNA position 769 ± 750). The human ski DNA fragment was ampli®ed by 30 cycle of 948C for 45 s, 638C for 30 s, and 728C for 1 min. PCR products were electrophoresed on 2% agarose gel. Data were analysed by accessing the server at http://www-genome.wi.mit.edu/cgibin/contig/rhmapper.pl. High resolution mapping was performed essentially as described by Lawrence et al. (1990) using¯uorescence in situ hybridization (FISH) signal mapping and the PAC clones encoding human c-ski gene, p73 gene, or D1S80 marker. Puri®ed PAC clone DNAs were labeled with either biotin dATP or digoxigenin dUTP by nick translation. Labeled probes were combined with sheared human DNA and hybridized as dierentially labeled pairs to interphase nuclei derived from PHA stimulated peripheral blood lymphocytes in a solution containing 50% formamide, 10% dextran sulfate, and 26SSC. Speci®c hybridization signals were detected by incubating the hybridized slides in uorescein conjugated anti-digoxigenin antibodies as well as Texas red avidin. Estimation of the distance between two locations was performed as described by van den Engh et al. (1992) .
Abbreviations c-ski, cellular ski proto-oncogene; c-Ski, c-ski gene product; DMBA, 9,10-dimethyl-1,2-benzanthracene; HDAC, histone deacetylase; MEFs, mouse embryonic ®broblasts; TGF-b, tumor growth factor-b
